日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Monocyte-mediated metabolic rewiring via CD31-CD38 interactions promotes growth and drug-resistance in multiple myeloma

单核细胞介导的代谢重编程通过 CD31-CD38 相互作用促进多发性骨髓瘤的生长和耐药性。

Raoof, Ramin; Dal Collo, Giada; Simon-Molas, Helga; Tzortzi, Panagiota; Kulaj, Konxhe; Demirez, Elif N; Massaro, Crescenzo; Poels, Renée; Korst, Charlotte L B M; O'Neill, Chloe A; Bruins, Wassilis S C; Broekmans, Marloes E C; Behradkia, Payam; Krevvata, Maria; Zweegman, Sonja; Kater, Arnon P; Baglio, Serena R; Mutis, Tuna; van de Donk, Niels W C J

Engineering of induced pluripotent stem cells for the efficient development of non-alloreactive, hypoimmunogenic CD8αβ CAR-T cells.

对诱导多能干细胞进行工程改造,以高效开发非同种异体反应性、低免疫原性的 CD8αβ CAR-T 细胞。

Nianias Alexandros, Katsarou Afroditi, Prins Henk Jan, Shahrabi Aida, van Velzen Cindy, Henneman Linda, Ruiter Ruud, Mutis Tuna, Groen Richard, Themeli Maria

Pharmacokinetic and pharmacodynamic evaluation of alternative pomalidomide dosing regimens in the treatment of multiple myeloma

多发性骨髓瘤治疗中泊马度胺替代给药方案的药代动力学和药效学评价

Seefat, M R; Cucchi, D G J; van Boven, L; Durdu-Rayman, N; Groen, K; Levin, M-D; de Heer, K; de Valk, B; Wester, R; van der Spek, E; Rentenaar, R; Korst, C L B M; Quik, M; O'Neill, C A; Tzortzi, P; Smits, F; Mathot, R; Heerma van Voss, M R; van de Donk, N W C J; Mutis, T; Bartelink, I H; Zweegman, S

Reduce oral health anesthetic emissions for the sake of health

为了健康,减少口腔麻醉剂的排放。

Nevison, M; Monopoli, M; Mutis, M; Gudsoorkar, P; Mehta, S

Immune signatures in older patients with newly diagnosed multiple myeloma are associated with survival outcomes of first-line therapy irrespective of frailty levels

老年新诊断多发性骨髓瘤患者的免疫特征与一线治疗的生存结果相关,且与患者的虚弱程度无关。

Bruins, Wassilis S C; Smits, Febe; Duetz, Carolien; Nasserinejad, Kazem; Groen, Kazimierz; Korst, Charlotte L B M; de Jonge, A Vera; Rentenaar, Rosa; Hageman, Tamara; Cosovic, Meliha; Eken, Merve; Twickler, Inoka; Homan-Weert, Paola M; Verkleij, Christie P M; Frerichs, Kristine; Levin, Mark-David; van der Spek, Ellen; Nijhof, Inger S; van Kampen, Roel; van de Donk, Niels W C J; Zweegman, Sonja; Mutis, Tuna

Emerging strategies in CAR-T cell therapy for acute myeloid leukemia: overcoming heterogeneity and improving safety through dual-antigen targeting

CAR-T细胞疗法治疗急性髓系白血病的新兴策略:通过双抗原靶向克服异质性并提高安全性

Ocaña-Cara, Ángeles; Mutis, Tuna; van der Schans, Jort J

Cytoskeletal dynamics and mitochondrial rearrangements drive cell fate upon antibody-induced complement activation in DLBCL

在弥漫性大B细胞淋巴瘤(DLBCL)中,抗体诱导的补体激活后,细胞骨架动力学和线粒体重排驱动细胞命运。

van der Horst, Hilma J; Csikós, Tamás; Quik, Marjolein; van der Schans, Jort J; de Lint, Klaas; Nuñez Moreno, Gonzalo; Guan, Meijian; Karagoz, Kubra; Breij, Esther C W; Santegoets, Kim C M; Chamuleau, Martine E D; Roukens, M Guy; Overdijk, Marije B; Mutis, Tuna

Human eyelid behavior is driven by segmental neural control of the orbicularis oculi

人类眼睑行为是由眼轮匝肌的节段性神经控制驱动的。

Kim, Jinyoung; Shirriff, Ashley; Cornwell, Jordan N; Mutis, Maria Paula Quintero; Delis, Ereni; Wang, Sophia; Rootman, Daniel B; Clites, Tyler R

Lymphoma-on-chip model reveals that lymph node stromal cells promote diffuse large B-cell lymphoma survival and migration

芯片淋巴瘤模型揭示淋巴结基质细胞促进弥漫性大B细胞淋巴瘤的存活和迁移

Mohammad Jouybar ,Aleksandra M Mikula ,Nanouk Zuidmeer ,Tanja Konijn ,A Vera de Jonge ,Henk P Roest ,Tuna Mutis ,Luc J W van der Laan ,Reina E Mebius ,Jaap M J den Toonder ,Charlotte M de Winde

Surface downmodulation of TIM3 safeguards healthy cells but not acute myeloid leukemia from CAR T-cell therapy

TIM3表面表达下调可保护健康细胞免受CAR-T细胞疗法的损伤,但不能保护急性髓系白血病细胞免受损伤。

Jort J van der Schans ,Paresh Vishwasrao ,Renée Poels ,Morgan Antti ,Ziyu Wang ,Marjolein Quik ,Jennemiek van Arkel ,Tom Reuvekamp ,Niels W C J van de Donk ,Maria Themeli ,Gert J Ossenkoppele ,Arjan A van de Loosdrecht ,Rebecca Richards ,Tuna Mutis